Сучасне лікування бешихи
Published in European Neurology • Jan 1, 2006
Authors:,,
Ніна Іванівна Ільїна
Нина Ивановна Ильина
Nina Ivanivna Ilina
Abstract
Effects of indeloxazine, a new compound which has been though to block reuptake of serotonin and noradrenaline, on cerebrospinal fluid monoamine metabolites were evaluated in 11 patients with dementia. Treatment with 90 mg/day of indeloxazine for 6-8 weeks resulted in significant reduction in methox...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!